Integrated network pharmacology and DSS-induced colitis model to determine the anti-colitis effect of Rheum palmatum L. and Coptis chinensis Franch in granules
Bibliographic Data
AKT1 · Colitis · Coptis · Coptis chinensis · Herb · Medicinal herbs · Pathology · PI3K/AKT/mTOR pathway · Signal transduction · Traditional Chinese medicine · Traditional medicine · Chemistry · Computational Drug Discovery Methods · Medicine · Pharmacological Effects of Natural Compounds · Phytochemistry and biological activity of medicinal plants · Biochemistry · Immunology · Pharmacology
Therapeutic efficacy of Sanhuang Xiexin decoction on atopic dermatitis via suppressing STAT3 signaling
Traditional Chinese Medicine formulas-based interventions on colorectal carcinoma prevention
Investigating the possible mechanism of Cornus officinalis in the therapy of ischemic stroke by UHPLC-Q-TOF-MS, network pharmacology, molecular docking, and experimental verification
Revealing the mechanism of Dahuang Huanglian Xiexin Decoction attenuates dysbiosis via IL-17 signaling pathway based on network pharmacology and experimental validation
Network Pharmacology Databases for Traditional Chinese Medicine
Inhibition effect of oxyepiberberine isolated from Coptis chinensis franch. On non-small cell lung cancer based on a network pharmacology approach and experimental validation
Compatibility art of traditional Chinese medicine
Anneslea fragrans Wall. ameliorates ulcerative colitis via inhibiting NF-κB and Mapk activation and mediating intestinal barrier integrity
Xiexin Tang ameliorates dyslipidemia in high-fat diet-induced obese rats via elevating gut microbiota-derived short chain fatty acids production and adjusting energy metabolism
Rhubarb Peony Decoction ameliorates ulcerative colitis in mice by regulating gut microbiota to restoring Th17/Treg balance
Pharmacokinetic alterations of rhubarb anthraquinones in experimental colitis induced by dextran sulfate sodium in the rat
| Unique citing works | 4 |
|---|---|
| Citations per year | 2 |
| Citation span | 2024 - 2026 (3) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 4 |